Figure 2.
Probability of generalized and prostate-cancer-specific anxiety over the initial surveillance period according to intolerance of uncertainty and urinary symptoms. Probabilities and p-values are derived from the repeated-measures multivariable models and are reported for the mean IUS score ± a half-standard deviation and urinary symptoms dichotomized into mild versus moderate/severe symptoms based on the IPSS.